Skip to main content

TABLE 4.

Immunization of hamsters with rB/HPIV3-G1 and/or rB/HPIV3-F1 induces resistance to challenge with HPIV3 and RSV 28 days postinfection

Immunizing virusa No. of animals Mean HPIV3 titerb (log10 TCID50/g ± SEd)
Mean RSV titerc (log10 PFU/g ± SEd)
Nasal turbinates Lungs Nasal turbinates Lungs
rB/HPIV3-G1 6 2.3 ± 0.1 (A) 3.1 ± 0.2 (A) 1.9 ± 0.2 (AB) ≤1.7 (A)
rB/HPIV3-F1 6 2.6 ± 0.2 (A) 3.1 ± 0.1 (A) 2.9 ± 0.4 (BC) 2.1 ± 0.2 (A)
rB/HPIV3-G1 and rB/HPIV3-F1 6 2.8 ± 0.2 (A) 2.8 ± 0.3 (A) 1.8 ± 0.1 (A) 1.9 ± 0.4 (A)
rB/HPIV3 6 2.3 ± 0.5 (A) 3.6 ± 0.4 (A) 4.1 ± 0.5 (C) 3.5 ± 0.4 (B)
RSV 6 5.6 ± 0.2 (B) 5.2 ± 0.2 (B) 1.9 ± 0.3 (AB) ≤1.7 (A)
a

Groups of six hamsters were inoculated intranasally with 106 TCID50 of the indicated PIV3 or 106 PFU of RSV in a 0.1-ml inoculum. Nasal turbinates and lungs were harvested 5 days later for virus titration. 

b

HPIV3 titrations were performed on LLC-MK2 cells. The limit of detectability of virus was 101.7 TCID50/g of tissue. 

c

Quantitation of RSV was determined by plaque enumeration on HEp-2 cells. The limit of detectability of virus was 101.7 PFU/g of tissue. 

d

Mean virus titers were assigned to similar groups (A, B, and C) by the Tukey-Kramer test. Within each column, mean titers with different letters are statistically different (P < 0.05). Titers indicated with two letters are not significantly different from those indicated with either letter.